The Numbers Are Embarrassing

The US spent $14,775 per person on healthcare in 2024. That's according to the Peterson-KFF Health System Tracker, using 2024 National Health Expenditure Data.

The next closest country? Switzerland — and the US still spent nearly $5,000 more per person than them.

The average comparable wealthy nation spent $7,860 per person. The US spent almost exactly double that.

As a share of the economy, the US dedicated 18 percent of GDP to healthcare in 2024, according to the Commonwealth Fund's latest analysis. The 19-country average was 9.3 percent. Germany was second-highest at 12.3 percent. The US is spending half again more than the second-place spender, and roughly double everyone else.

Total national tab: $5.3 trillion, according to Seattle Red's coverage citing 2024 data.

What Americans Got for That Money

NOT better health outcomes.

US life expectancy sits at 79 years — third lowest among the 20 countries studied, per the Commonwealth Fund. The overall average was 81.2 years. Spain hits 84. Japan hits 84.1. Switzerland tops out at 84.3.

The US had the second-highest avoidable mortality rate — deaths from conditions that primary care can prevent or timely treatment can fix. Only Mexico ranked worse.

Maternal mortality? The US leads the pack at nearly 19 deaths per 100,000 live births in 2023, the highest of any country in the study.

And Americans are, by far, the most likely to skip medications, skip tests, and avoid doctor visits because they can't afford them. More spending. Less access. Worse results.

The Supply Problem Nobody Talks About

The US has the fewest primary care providers per capita of any country in the study.

0.3 primary care providers per 1,000 people. The average across all 20 countries is 1.1. Australia and the Netherlands hit 1.8. That's not a funding problem — that's a supply problem.

The US also produces new physicians at one of the lowest rates in the study and carries among the lowest hospital bed capacity levels, according to the Commonwealth Fund report.

You cannot fix a supply shortage by adding more government payers. That's a basic market reality the single-payer crowd skips right over.

Where the Mainstream Coverage Goes Wrong

Left-leaning outlets like Ars Technica headline this as the system being "stupidly expensive" with "pathetic outcomes" — which is accurate on the numbers but skips straight to an implicit single-payer conclusion without examining the actual causes.

On the other side, Seattle Red's coverage raises a fair point: the two most-cited international ranking systems — the WHO and the Commonwealth Fund — bake equity and universal coverage assumptions into their methodology before the data even runs. The WHO's ranking criteria, per Seattle Red's analysis citing the WHO's own study design, weights at least 62.5 percent on having a government-run or single-payer system. A country without universal coverage starts in a hole before a single patient outcome is measured.

That's a legitimate methodological critique. It doesn't make the spending gap disappear — those are hard numbers — but it means the rankings themselves are partly measuring "does your system look like what we think it should look like" rather than purely "are people healthy."

What the Data Actually Shows vs. What People Claim It Shows

The KFF analysis from Emma Wager and Cynthia Cox makes an honest acknowledgment: "some of this disparity can be attributed to aspects of the US health system, but socioeconomic, health, and other factors also play a role."

The US has higher rates of obesity, gun violence, car accidents, and drug overdoses than peer countries. Those kill people and drive up costs. That's NOT solely a healthcare system problem. Single payer doesn't fix obesity rates or fentanyl.

At the same time, 40 percent of Americans already get their healthcare through Medicare, Medicaid, or ACA exchanges, as Seattle Red notes. The government is already the dominant player. If government management alone fixed outcomes, we'd see it.

The Real Problems Nobody Wants to Name

Problem 1: Pharmaceutical prices. The US pays dramatically more for the same drugs than every other country. Other nations negotiate. The US largely doesn't. That's a policy choice with a dollar amount attached.

Problem 2: Administrative bloat. A massive chunk of US healthcare spending goes to billing, compliance, and insurance bureaucracy — NOT to doctors or patients.

Problem 3: Physician supply is artificially constrained. Medical school slots, residency programs, and licensing requirements limit doctor supply. Fewer doctors, higher prices.

Problem 4: Third-party payment insulates consumers from real costs. When someone else pays, nobody price-shops. When nobody price-shops, prices go up.

What This Means for Regular People

You are paying, through taxes, premiums, and out-of-pocket costs, the equivalent of a second mortgage compared to what citizens of peer countries pay — and you are dying younger for it.

The system has failed. It has persisted through Republican and Democratic administrations, through the ACA, through Medicare expansion, through everything.

The fix isn't simply "government runs everything" — that's not what the data proves and it ignores the supply side entirely. But the current system is also NOT a free market. It's a government-tangled, administratively bloated, monopoly-protected mess that somehow produces the worst of both worlds.

Someone is getting rich. It isn't you.